Skip to main content

Advertisement

SpringerLink
Log in

MMP polymorphisms and HIV antiretroviral drugs

Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches

  • News and Commentary
  • Published:
The Pharmacogenomics Journal Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Malemud CJ . Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006; 11: 1696–1701.

    Article  CAS  PubMed  Google Scholar 

  2. Mannello F, Luchetti F, Falcieri E, Papa S . Multiple roles of matrix metalloproteinases during apoptosis. Apoptosis 2005; 10: 19–24.

    Article  CAS  PubMed  Google Scholar 

  3. Visse R, Nagase H . Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827–839.

    Article  CAS  PubMed  Google Scholar 

  4. Mannello F, Tonti G, Bagnara GP, Papa S . Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cell. Stem Cells 2006; 24: 475–481.

    Article  CAS  PubMed  Google Scholar 

  5. Brinckerhoff CE, Matrisian LM . Matrix metalloproteinases: a tail of a frog that became a prince. Nature 2002; 3: 207–214.

    CAS  Google Scholar 

  6. Mannello F, Tonti G, Papa S . Matrix metalloproteinase inhibitors as anticancer therapeutics. Curr Cancer Drug Target 2005; 5: 285–298.

    Article  CAS  Google Scholar 

  7. Elkington PTG, O'Kane CM, Friedland JS . The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005; 142: 12–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Webster NL, Crowe SM . Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leuk Biol 2006; 80: 1052–1066.

    Article  CAS  Google Scholar 

  9. Mastroianni CM, Liuzzi GM . Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies. Trends Mol Med 2007; 13: 449–459.

    Article  CAS  PubMed  Google Scholar 

  10. Mannello F . Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon? Recent Patent Drug Discov 2006; 1: 91–103.

    Article  CAS  Google Scholar 

  11. Mannello F, Tonti GA . Statins and breast cancer: may matrix metalloproteinase be the missing link? Cancer Invest 2009; 27: 466–470.

    Article  CAS  PubMed  Google Scholar 

  12. Latronico T, Liuzzi GM, Riccio P, Lichtner M, Mengoni F, D'Agostino C et al. Antiretroviral therapy inhibits matrix metalloproteinase-9 from mononuclear cells of HIV-infected patients. AIDS 2007; 21: 677–684.

    Article  PubMed  Google Scholar 

  13. Cressey TR, Lallemant M . Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update. Infect Genet Evol 2007; 7: 333–342.

    Article  CAS  PubMed  Google Scholar 

  14. Mahungu TW, Johnson MA, Owen A, Back DJ . The impact of pharmacogenetics on HIV therapy. Int J STD AIDS 2009; 20: 145–151.

    Article  CAS  PubMed  Google Scholar 

  15. Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Tanus-Santos JE . A matrix metalloproteinase 9 (MMP-9) polymorphism affects highly active antiretroviral therapy-induced changes in circulating MMP-9 levels in HIV patients. Pharmacogenomics J 2009; 9: 265–273.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomolecular Sciences, Section of Clinical Biochemistry, Faculty of Sciences and Technologies, University ‘Carlo Bo’, Via O, Ubaldini 7, Urbino, (PU) 61029, Italy

    F Mannello

Authors
  1. F Mannello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Mannello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mannello, F. Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches. Pharmacogenomics J 9, 355–357 (2009). https://doi.org/10.1038/tpj.2009.35

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2009.35

  • Springer Nature Limited

Search

Navigation